- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02062476
Epigenetic Effects Elicited By Lactobacillus GG In Children With Cow's Milk Allergy
EPIGENETIC EFFECTS ELICITED BY LACTOBACILLUS GG IN CHILDREN WITH COW'S MILK ALLERGY: A POSSIBLE EFFECT OF ATOPIC MARCH
Lactobacillus GG (LGG) is able to exert long lasting effects in children with atopic disorders. We have shown that Nutramigen LGG accelerates tolerance acquisition in infants with cow's milk allergy (CMA). The mechanisms of these effects are still largely undefined. The effect of LGG could be related at least in part by the immunoregulatory role played by LGG. This probiotic can balance the generation of cytokines possibly involved in IgE- or non-IgE-mediated CMA (i.e., IL-4, IL-5, IL-10, IFN-γ , TGF-beta, and TNF-alfa), which can contribute to modulation of inflammatory processes. We have demonstrated that children with IgE-mediated CMA produce significantly higher level of IL-4 and IL-13 in response to cow's milk protein, and that tolerance is associated with a marked reduction of IL-13 production and a concomitant increased frequency of IFN-γ releasing cells.
Epigenetics studies the heritable (and potentially reversible) changes of the genome inherited from one cell generation to the next which alter gene expression but do not involve changes in primary DNA sequences, highlighting the complexity of the inter-relationship between genetics and nutrition. There are three distinct, but closely interacting, epigenetic mechanisms (histone acetylation, DNA methylation, and non-coding microRNAs) that are responsible for modifying the expression of critical genes associated with physiologic and pathologic processes. The profile of epigenetic modifications associated with Th lineage commitment, coupled with the sensitivity of the early developmental period, has led to speculation that factors that disrupt these pathways may increase the risk of allergic diseases. Specifically, effects on DNA methylation and endogenous histone deacetylase inhibitors acting on specific pathways (Th1 and T regulatory cell differentiation) may favour Th2-associated allergic differentiation. MicroRNAs are another structural components of an epigenetic mechanism of post-transcriptional regulation of messenger RNA translation. It has been recently identified a specific Th2-associated miRNA (miR-21) that is critical for the regulation of Th cell polarization.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
Contacts and Locations
Study Contact
- Name: Roberto Berni Canani, MD, PhD
- Phone Number: 0817462680
Study Locations
-
-
-
Naples, Italy, 80131
- Recruiting
- University of Naples Federico II
-
Contact:
- Roberto Berni Canani
- Phone Number: 0817462680
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children aged 4 months-4 years with cow's milk allergy
Exclusion Criteria:
- age higher than 4 years,
- concomitant chronic systemic diseases,
- congenital cardiac defects,
- active tuberculosis,
- autoimmune diseases,
- immunodeficiency,
- chronic inflammatory bowel diseases,
- celiac disease,
- cystic fibrosis,
- metabolic diseases,
- malignancy,
- chronic pulmonary diseases,
- malformations of the gastrointestinal tract,
- suspected eosinophilic esophagitis or eosinophilic enterocolitis,
- suspected food-protein-induced enterocolitis syndrome,
- suspected cow's milk protein-induced anaphylaxis.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Treatment with Lactobacillus GG
extensively hydrolyzed casein formula containing LGG
|
|
No Intervention: Children at diagnosis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline to 6 months in tolerance acquisition and epigenetic effects in rtwenty children with cow's milk allergy
Time Frame: Baseline, at least after 6 months of therapy
|
The investigators will evaluate in children with CMA if the effect of Lactobacillus GG on tolerance acquisition is mediated at least in part by an epigenetic mechanism.
|
Baseline, at least after 6 months of therapy
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1/14
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cow's Milk Allergy
-
University of Campinas, BrazilCompleted
-
Edetec Indústria Alimentícia S.A.Federal University of Minas Gerais; Faculdade de Ciências Médicas de Minas...CompletedCow's Milk Allergy
-
Laboratorios OrdesaSprim Advanced Life SciencesTerminatedCow's Milk AllergySpain, France
-
Federico II UniversityRecruiting
-
Société des Produits Nestlé (SPN)Completed
-
Assistance Publique - Hôpitaux de ParisESPCI ParisCompleted
-
Martini Hospital GroningenRecruitingCow Milk Allergy | Food AllergyNetherlands
-
University GhentActive, not recruitingCow Milk Allergy | Food AllergyBelgium
-
Federico II UniversityUnknown
Clinical Trials on Lactobacillus GG
-
National Institute of Pediatrics, MexicoNekutli S.A. de C.V.Completed
-
Duke UniversityCompletedMicrobiomeUnited States
-
Tufts Medical CenterTerminatedVancomycin Resistant Enterococcal ColonizationUnited States
-
Groningen Research Institute for Asthma and COPDNumico Research Wageningen, the NetherlandsCompletedAtopic Dermatitis | Atopic Eczema | Infantile EczemaNetherlands
-
Michael E. DeBakey VA Medical CenterBaylor College of MedicineWithdrawnEnterocolitis | Pseudomembranous Colitis | Antibiotic-associated ColitisUnited States
-
Pablo Román LópezCompleted
-
Shriners Hospitals for ChildrenTerminated
-
Virginia Commonwealth UniversityNational Center for Complementary and Integrative Health (NCCIH)CompletedMinimal Hepatic EncephalopathyUnited States
-
Medical University of WarsawUnknownRespiratory Tract Infections | Gastroesophageal Reflux Disease | Gastrointestinal InfectionsPoland
-
Creighton UniversityCompletedPneumonia | Ventilator Associated PneumoniaUnited States